News
The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in ...
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib ... with histologically confirmed recurrent or persistent USC were eligible if they had ...
Hosted on MSN8mon
Nir Seroussi Accepts Hot Latin Songs Label of The Year | Latin Music Power Players 2024 - MSNNir Seroussi from Interscope Records accepts the Hot Latin Songs Label of the Year award from Billboard’s Chief Content Officer of Latin Music and Billboard Español, Leila Cobo at Billboard’s ...
The serosa secretes a cuticle of hard, impermeable chitin below the eggshell, which restricts the flow of water through the egg. In an earlier experiment, van der Zee had used a technique called ...
Nir Seroussi Exits Sony Music U.S. Latin; Alex Gallardo Named Label President: Exclusive - Billboard
Nir Seroussi has exited his post as president, Sony Music U.S. Latin, Billboard has learned. Effective immediately, Alex Gallardo, the longtime senior vp A&R for Sony Latin/Iberia, will take over ...
Nir Seroussi from Interscope Records accepts the Hot Latin Songs Label of the Year award at Billboard’s Latin Music Power Players 2024.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results